Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Potential Cardiovascular Disease Treatment by Natural Drugs Targeting the HIF-1α Factor and its Pathway
Weihan Gao1, Danyang Wang1, Yanmei Shi2
1Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Insights
Hypoxia-inducible factor-1α (HIF-1α) is a key target for treating cardiovascular diseases (CVDs). This study reviews natural drugs and traditional Chinese medicine that target HIF-1α signaling for effective CVD prevention and treatment.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Pharmacology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death globally.
- Hypoxia-inducible factor-1α (HIF-1α) plays a critical role in regulating cellular responses to hypoxia and is implicated in CVD pathogenesis.
- Natural products, particularly from traditional Chinese medicine, are gaining attention for their therapeutic potential in CVDs.
Purpose of the Study:
- To elucidate the mechanism of HIF-1α in regulating CVDs.
- To identify and summarize natural drugs and formulations targeting the HIF-1α pathway for CVD treatment.
- To provide novel insights for the prevention and treatment of CVDs using natural interventions.
Main Methods:
- Literature review of studies on HIF-1α and cardiovascular diseases.
- Analysis of the regulatory mechanisms of HIF-1α in CVDs.
- Compilation of natural drugs and traditional Chinese medicine formulations targeting HIF-1α signaling.
Main Results:
- Detailed description of HIF-1α's role in CVD mechanisms.
- Identification of 30 natural drugs with potential CVD therapeutic effects via HIF-1α.
- Summary of 3 traditional Chinese medicine formulations targeting the HIF-1α pathway.
Conclusions:
- HIF-1α is a significant therapeutic target for cardiovascular diseases.
- Natural drugs and traditional Chinese medicine formulations targeting HIF-1α offer promising avenues for CVD treatment.
- This review provides a foundation for developing new natural-based strategies for CVD prevention and management.
Abstract:
Cardiovascular diseases (CVDs) remain a key contributor to global morbidity and mortality. Being a vital regulator of hypoxia, hypoxia-inducible factor-1α (HIF-1α) is a crucial player in CVD treatment. Recently, increasing attention has been paid to the effect of natural drugs on CVDs. According to some studies, HIF-1α is a potential target for CVD treatment in traditional Chinese medicine. In this study, we describe the mechanism underlying the regulatory role of HIF-1α in CVDs and summarize 30 natural drugs and 3 formulations for CVD treatment through HIF-1α and its signaling pathway. The study provides new ideas for CVD prevention and treatment.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

